{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Merge all the trails"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import json\n",
    "\n",
    "def merge_csv_by_columns(folder_path, output_file):\n",
    "    # List all CSV files in the folder\n",
    "    csv_files = [file for file in os.listdir(folder_path) if file.endswith('.csv')]\n",
    "\n",
    "    # Initialize an empty list to store DataFrames\n",
    "    dataframes = []\n",
    "\n",
    "    # Read each CSV file and append it to the list\n",
    "    for file in csv_files:\n",
    "        df = pd.read_csv(os.path.join(folder_path, file))\n",
    "        dataframes.append(df)\n",
    "\n",
    "    # Merge all DataFrames based on common column names\n",
    "    merged_df = pd.concat(dataframes, ignore_index=True, sort=False)\n",
    "\n",
    "    # Remove rows where 'location' is empty\n",
    "    # merged_df = merged_df.dropna(subset=['Locations'])\n",
    "\n",
    "    # Remove duplicate rows\n",
    "    merged_df = merged_df.drop_duplicates()\n",
    "\n",
    "    # Save the merged DataFrame to a new CSV file\n",
    "    merged_df.to_csv(output_file, index=False)\n",
    "\n",
    "    return merged_df\n",
    "\n",
    "# Example usage\n",
    "folder_path = './trials/'\n",
    "output_file = 'merged_output.csv'\n",
    "clinical_trails_data = merge_csv_by_columns(folder_path, output_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03334747</td>\n",
       "      <td>Safety of KAE609 in Adults With Uncomplicated ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03334747</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>KAE609 will be evaluated primarily for hepatic...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: KAE609|DRUG: Coartem</td>\n",
       "      <td>Number of Participants With at Least 2 CTCAE G...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CKAE609A2202|207813/Z/17/Z</td>\n",
       "      <td>2017-11-16</td>\n",
       "      <td>2019-11-23</td>\n",
       "      <td>2019-11-23</td>\n",
       "      <td>2017-11-07</td>\n",
       "      <td>2020-09-03</td>\n",
       "      <td>2021-10-11</td>\n",
       "      <td>Novartis Investigative Site, Lambarene, Gabon|...</td>\n",
       "      <td>Study Protocol, https://storage.googleapis.com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01190202</td>\n",
       "      <td>Epidemiology Study of Malaria Transmission Int...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01190202</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The aim of this epidemiology study is to chara...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria|Malaria Vaccines</td>\n",
       "      <td>PROCEDURE: Blood sampling|PROCEDURE: Assessmen...</td>\n",
       "      <td>Number of Subjects With Plasmodium Falciparum ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>114001</td>\n",
       "      <td>2011-03-14</td>\n",
       "      <td>2013-12-20</td>\n",
       "      <td>2013-12-20</td>\n",
       "      <td>2010-08-27</td>\n",
       "      <td>2017-09-29</td>\n",
       "      <td>2020-08-18</td>\n",
       "      <td>GSK Investigational Site, Ouagadougou 01, Burk...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01955382</td>\n",
       "      <td>Evaluation of Oral Activated Charcoal on Antim...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01955382</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Background:\\n\\n- Malaria is caused by small pa...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria|Severe Malaria</td>\n",
       "      <td>DRUG: Actidose Aqua|DRUG: Artesunate|DRUG: Amo...</td>\n",
       "      <td>Parasite Clearance Half-life, To compare paras...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>999913209|13-I-N209|NCT01955382</td>\n",
       "      <td>2013-09</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>2013-10-07</td>\n",
       "      <td>2017-04-20</td>\n",
       "      <td>2018-02-06</td>\n",
       "      <td>Universite des Sciencies, Techniques et Techno...</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01465048</td>\n",
       "      <td>Optimisation of Controlled Human Malaria Infec...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01465048</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an open label, human pilot study to op...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria|Plasmodium Falciparum</td>\n",
       "      <td>BIOLOGICAL: Plasmodium falciparum sporozoites ...</td>\n",
       "      <td>Number of Participants Infected, To determine ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>VAC049</td>\n",
       "      <td>2011-10</td>\n",
       "      <td>2012-02</td>\n",
       "      <td>2013-02</td>\n",
       "      <td>2011-11-04</td>\n",
       "      <td>2013-04-08</td>\n",
       "      <td>2013-06-24</td>\n",
       "      <td>Centre for Clinical Vaccinology and Tropical M...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02458092</td>\n",
       "      <td>Evaluate the Safety and Efficacy of Plasmodium...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02458092</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>BIOLOGICAL: Plasmodium falciparum Malaria Prot...</td>\n",
       "      <td>Number of Participants With Solicited Adverse ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>A-14620.b|WRAIR 1417</td>\n",
       "      <td>2008-04</td>\n",
       "      <td>2008-12</td>\n",
       "      <td>2009-06</td>\n",
       "      <td>2015-05-29</td>\n",
       "      <td>2018-11-07</td>\n",
       "      <td>2023-06-28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT03334747  Safety of KAE609 in Adults With Uncomplicated ...   \n",
       "1  NCT01190202  Epidemiology Study of Malaria Transmission Int...   \n",
       "2  NCT01955382  Evaluation of Oral Activated Charcoal on Antim...   \n",
       "3  NCT01465048  Optimisation of Controlled Human Malaria Infec...   \n",
       "4  NCT02458092  Evaluate the Safety and Efficacy of Plasmodium...   \n",
       "\n",
       "                                      Study URL Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT03334747     NaN    COMPLETED   \n",
       "1  https://clinicaltrials.gov/study/NCT01190202     NaN    COMPLETED   \n",
       "2  https://clinicaltrials.gov/study/NCT01955382     NaN    COMPLETED   \n",
       "3  https://clinicaltrials.gov/study/NCT01465048     NaN    COMPLETED   \n",
       "4  https://clinicaltrials.gov/study/NCT02458092     NaN    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  KAE609 will be evaluated primarily for hepatic...           YES   \n",
       "1  The aim of this epidemiology study is to chara...           YES   \n",
       "2  Background:\\n\\n- Malaria is caused by small pa...           YES   \n",
       "3  This is an open label, human pilot study to op...           YES   \n",
       "4  The purpose of this study is to determine whet...           YES   \n",
       "\n",
       "                      Conditions  \\\n",
       "0                        Malaria   \n",
       "1       Malaria|Malaria Vaccines   \n",
       "2         Malaria|Severe Malaria   \n",
       "3  Malaria|Plasmodium Falciparum   \n",
       "4                        Malaria   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                         DRUG: KAE609|DRUG: Coartem   \n",
       "1  PROCEDURE: Blood sampling|PROCEDURE: Assessmen...   \n",
       "2  DRUG: Actidose Aqua|DRUG: Artesunate|DRUG: Amo...   \n",
       "3  BIOLOGICAL: Plasmodium falciparum sporozoites ...   \n",
       "4  BIOLOGICAL: Plasmodium falciparum Malaria Prot...   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Number of Participants With at Least 2 CTCAE G...  ...   \n",
       "1  Number of Subjects With Plasmodium Falciparum ...  ...   \n",
       "2  Parasite Clearance Half-life, To compare paras...  ...   \n",
       "3  Number of Participants Infected, To determine ...  ...   \n",
       "4  Number of Participants With Solicited Adverse ...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "                         Other IDs  Start Date Primary Completion Date  \\\n",
       "0       CKAE609A2202|207813/Z/17/Z  2017-11-16              2019-11-23   \n",
       "1                           114001  2011-03-14              2013-12-20   \n",
       "2  999913209|13-I-N209|NCT01955382     2013-09                 2015-07   \n",
       "3                           VAC049     2011-10                 2012-02   \n",
       "4             A-14620.b|WRAIR 1417     2008-04                 2008-12   \n",
       "\n",
       "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
       "0      2019-11-23   2017-11-07           2020-09-03          2021-10-11   \n",
       "1      2013-12-20   2010-08-27           2017-09-29          2020-08-18   \n",
       "2         2015-07   2013-10-07           2017-04-20          2018-02-06   \n",
       "3         2013-02   2011-11-04           2013-04-08          2013-06-24   \n",
       "4         2009-06   2015-05-29           2018-11-07          2023-06-28   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  Novartis Investigative Site, Lambarene, Gabon|...   \n",
       "1  GSK Investigational Site, Ouagadougou 01, Burk...   \n",
       "2  Universite des Sciencies, Techniques et Techno...   \n",
       "3  Centre for Clinical Vaccinology and Tropical M...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                     Study Documents  \n",
       "0  Study Protocol, https://storage.googleapis.com...  \n",
       "1                                                NaN  \n",
       "2  Study Protocol and Statistical Analysis Plan, ...  \n",
       "3                                                NaN  \n",
       "4                                                NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clinical_trails_data.head(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Preprocess the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "def preprocess(merged_df):\n",
    "    for col in df.columns:\n",
    "        if df[col].dtype == object:\n",
    "            df[col] = df[col].str.lower()\n",
    "        df[col] = df[col].fillna('')\n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>nct03334747</td>\n",
       "      <td>safety of kae609 in adults with uncomplicated ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/nct03334747</td>\n",
       "      <td></td>\n",
       "      <td>completed</td>\n",
       "      <td>kae609 will be evaluated primarily for hepatic...</td>\n",
       "      <td>yes</td>\n",
       "      <td>malaria</td>\n",
       "      <td>drug: kae609|drug: coartem</td>\n",
       "      <td>number of participants with at least 2 ctcae g...</td>\n",
       "      <td>...</td>\n",
       "      <td>allocation: randomized|intervention model: par...</td>\n",
       "      <td>ckae609a2202|207813/z/17/z</td>\n",
       "      <td>2017-11-16</td>\n",
       "      <td>2019-11-23</td>\n",
       "      <td>2019-11-23</td>\n",
       "      <td>2017-11-07</td>\n",
       "      <td>2020-09-03</td>\n",
       "      <td>2021-10-11</td>\n",
       "      <td>novartis investigative site, lambarene, gabon|...</td>\n",
       "      <td>study protocol, https://storage.googleapis.com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>nct01190202</td>\n",
       "      <td>epidemiology study of malaria transmission int...</td>\n",
       "      <td>https://clinicaltrials.gov/study/nct01190202</td>\n",
       "      <td></td>\n",
       "      <td>completed</td>\n",
       "      <td>the aim of this epidemiology study is to chara...</td>\n",
       "      <td>yes</td>\n",
       "      <td>malaria|malaria vaccines</td>\n",
       "      <td>procedure: blood sampling|procedure: assessmen...</td>\n",
       "      <td>number of subjects with plasmodium falciparum ...</td>\n",
       "      <td>...</td>\n",
       "      <td>allocation: na|intervention model: single_grou...</td>\n",
       "      <td>114001</td>\n",
       "      <td>2011-03-14</td>\n",
       "      <td>2013-12-20</td>\n",
       "      <td>2013-12-20</td>\n",
       "      <td>2010-08-27</td>\n",
       "      <td>2017-09-29</td>\n",
       "      <td>2020-08-18</td>\n",
       "      <td>gsk investigational site, ouagadougou 01, burk...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>nct01955382</td>\n",
       "      <td>evaluation of oral activated charcoal on antim...</td>\n",
       "      <td>https://clinicaltrials.gov/study/nct01955382</td>\n",
       "      <td></td>\n",
       "      <td>completed</td>\n",
       "      <td>background:\\n\\n- malaria is caused by small pa...</td>\n",
       "      <td>yes</td>\n",
       "      <td>malaria|severe malaria</td>\n",
       "      <td>drug: actidose aqua|drug: artesunate|drug: amo...</td>\n",
       "      <td>parasite clearance half-life, to compare paras...</td>\n",
       "      <td>...</td>\n",
       "      <td>allocation: randomized|intervention model: par...</td>\n",
       "      <td>999913209|13-i-n209|nct01955382</td>\n",
       "      <td>2013-09</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>2015-07</td>\n",
       "      <td>2013-10-07</td>\n",
       "      <td>2017-04-20</td>\n",
       "      <td>2018-02-06</td>\n",
       "      <td>universite des sciencies, techniques et techno...</td>\n",
       "      <td>study protocol and statistical analysis plan, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>nct01465048</td>\n",
       "      <td>optimisation of controlled human malaria infec...</td>\n",
       "      <td>https://clinicaltrials.gov/study/nct01465048</td>\n",
       "      <td></td>\n",
       "      <td>completed</td>\n",
       "      <td>this is an open label, human pilot study to op...</td>\n",
       "      <td>yes</td>\n",
       "      <td>malaria|plasmodium falciparum</td>\n",
       "      <td>biological: plasmodium falciparum sporozoites ...</td>\n",
       "      <td>number of participants infected, to determine ...</td>\n",
       "      <td>...</td>\n",
       "      <td>allocation: non_randomized|intervention model:...</td>\n",
       "      <td>vac049</td>\n",
       "      <td>2011-10</td>\n",
       "      <td>2012-02</td>\n",
       "      <td>2013-02</td>\n",
       "      <td>2011-11-04</td>\n",
       "      <td>2013-04-08</td>\n",
       "      <td>2013-06-24</td>\n",
       "      <td>centre for clinical vaccinology and tropical m...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>nct02458092</td>\n",
       "      <td>evaluate the safety and efficacy of plasmodium...</td>\n",
       "      <td>https://clinicaltrials.gov/study/nct02458092</td>\n",
       "      <td></td>\n",
       "      <td>completed</td>\n",
       "      <td>the purpose of this study is to determine whet...</td>\n",
       "      <td>yes</td>\n",
       "      <td>malaria</td>\n",
       "      <td>biological: plasmodium falciparum malaria prot...</td>\n",
       "      <td>number of participants with solicited adverse ...</td>\n",
       "      <td>...</td>\n",
       "      <td>allocation: randomized|intervention model: par...</td>\n",
       "      <td>a-14620.b|wrair 1417</td>\n",
       "      <td>2008-04</td>\n",
       "      <td>2008-12</td>\n",
       "      <td>2009-06</td>\n",
       "      <td>2015-05-29</td>\n",
       "      <td>2018-11-07</td>\n",
       "      <td>2023-06-28</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  nct03334747  safety of kae609 in adults with uncomplicated ...   \n",
       "1  nct01190202  epidemiology study of malaria transmission int...   \n",
       "2  nct01955382  evaluation of oral activated charcoal on antim...   \n",
       "3  nct01465048  optimisation of controlled human malaria infec...   \n",
       "4  nct02458092  evaluate the safety and efficacy of plasmodium...   \n",
       "\n",
       "                                      Study URL Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/nct03334747            completed   \n",
       "1  https://clinicaltrials.gov/study/nct01190202            completed   \n",
       "2  https://clinicaltrials.gov/study/nct01955382            completed   \n",
       "3  https://clinicaltrials.gov/study/nct01465048            completed   \n",
       "4  https://clinicaltrials.gov/study/nct02458092            completed   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  kae609 will be evaluated primarily for hepatic...           yes   \n",
       "1  the aim of this epidemiology study is to chara...           yes   \n",
       "2  background:\\n\\n- malaria is caused by small pa...           yes   \n",
       "3  this is an open label, human pilot study to op...           yes   \n",
       "4  the purpose of this study is to determine whet...           yes   \n",
       "\n",
       "                      Conditions  \\\n",
       "0                        malaria   \n",
       "1       malaria|malaria vaccines   \n",
       "2         malaria|severe malaria   \n",
       "3  malaria|plasmodium falciparum   \n",
       "4                        malaria   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                         drug: kae609|drug: coartem   \n",
       "1  procedure: blood sampling|procedure: assessmen...   \n",
       "2  drug: actidose aqua|drug: artesunate|drug: amo...   \n",
       "3  biological: plasmodium falciparum sporozoites ...   \n",
       "4  biological: plasmodium falciparum malaria prot...   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  number of participants with at least 2 ctcae g...  ...   \n",
       "1  number of subjects with plasmodium falciparum ...  ...   \n",
       "2  parasite clearance half-life, to compare paras...  ...   \n",
       "3  number of participants infected, to determine ...  ...   \n",
       "4  number of participants with solicited adverse ...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  allocation: randomized|intervention model: par...   \n",
       "1  allocation: na|intervention model: single_grou...   \n",
       "2  allocation: randomized|intervention model: par...   \n",
       "3  allocation: non_randomized|intervention model:...   \n",
       "4  allocation: randomized|intervention model: par...   \n",
       "\n",
       "                         Other IDs  Start Date Primary Completion Date  \\\n",
       "0       ckae609a2202|207813/z/17/z  2017-11-16              2019-11-23   \n",
       "1                           114001  2011-03-14              2013-12-20   \n",
       "2  999913209|13-i-n209|nct01955382     2013-09                 2015-07   \n",
       "3                           vac049     2011-10                 2012-02   \n",
       "4             a-14620.b|wrair 1417     2008-04                 2008-12   \n",
       "\n",
       "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
       "0      2019-11-23   2017-11-07           2020-09-03          2021-10-11   \n",
       "1      2013-12-20   2010-08-27           2017-09-29          2020-08-18   \n",
       "2         2015-07   2013-10-07           2017-04-20          2018-02-06   \n",
       "3         2013-02   2011-11-04           2013-04-08          2013-06-24   \n",
       "4         2009-06   2015-05-29           2018-11-07          2023-06-28   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  novartis investigative site, lambarene, gabon|...   \n",
       "1  gsk investigational site, ouagadougou 01, burk...   \n",
       "2  universite des sciencies, techniques et techno...   \n",
       "3  centre for clinical vaccinology and tropical m...   \n",
       "4                                                      \n",
       "\n",
       "                                     Study Documents  \n",
       "0  study protocol, https://storage.googleapis.com...  \n",
       "1                                                     \n",
       "2  study protocol and statistical analysis plan, ...  \n",
       "3                                                     \n",
       "4                                                     \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "preprocessed_trials = preprocess(clinical_trails_data)\n",
    "preprocessed_trials.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Convert the CSV data to a JSON-like structure (Original Code)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct03334747\",\n",
      "            \"Title\": \"safety of kae609 in adults with uncomplicated plasmodium falciparum malaria.\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct03334747\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"kae609 will be evaluated primarily for hepatic safety of single and multiple doses in sequential cohorts with increasing doses.this study aims to determine the maximum safe dose of the investigational drug kae609 in malaria patients.\",\n",
      "            \"Phase\": \"phase2\",\n",
      "            \"Study Start Date\": \"2017-11-16\",\n",
      "            \"Expected Completion Date\": \"2019-11-23\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug Name\": \"drug: kae609|drug: coartem\"\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": \"malaria\"\n",
      "        },\n",
      "        \"Locations\": {\n",
      "            \"Location Name\": \"novartis investigative site, lambarene, gabon|novartis investigative site, kintampo, ghana|novartis investigative site, navrango, ghana|novartis investigative site, bamako, mali|novartis investigative site, sotuba, mali|novartis investigative site, kigali, rwanda|novartis investigative site, bushenyi, uganda|novartis investigative site, kampala, uganda|novartis investigative site, tororo, uganda\"\n",
      "        }\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct01190202\",\n",
      "            \"Title\": \"epidemiology study of malaria transmission intensity in africa\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct01190202\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"the aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (nct00866619).\",\n",
      "            \"Phase\": \"\",\n",
      "            \"Study Start Date\": \"2011-03-14\",\n",
      "            \"Expected Completion Date\": \"2013-12-20\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug Name\": \"procedure: blood sampling|procedure: assessment of body temperature\"\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": \"malaria|malaria vaccines\"\n",
      "        },\n",
      "        \"Locations\": {\n",
      "            \"Location Name\": \"gsk investigational site, ouagadougou 01, burkina faso|gsk investigational site, lambar\\u00e9n\\u00e9, gabon|gsk investigational site, kintampo, ghana|gsk investigational site, kumasi, ghana|gsk investigational site, kisumu, kenya|gsk investigational site, lilongwe, malawi|gsk investigational site, dar-es-salaam, tanzania|gsk investigational site, korogwe, tanga, tanzania\"\n",
      "        }\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct01955382\",\n",
      "            \"Title\": \"evaluation of oral activated charcoal on antimalarial drug's ability to kill parasites in malian children with malaria\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct01955382\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"background:\\n\\n- malaria is caused by small parasites carried by some mosquitoes. people can get malaria if an infected mosquito bites them. malaria destroys red blood cells. most malaria is mild, but some children develop severe malaria, which kills about 660,000 people annually. about 9 in 10 who die of malaria are sub-saharan african children, most under 5 years old. scientists can save many lives if they find out how to prevent or relieve severe malaria.\\n\\nobjective:\\n\\n- to know if a common medicine called activated charcoal can reduce severe malaria symptoms.\\n\\neligibility:\\n\\n- children 2 to 11 years old with mild malaria who live in kenieroba, mali.\\n\\ndesign:\\n\\n* for the first 2 days and nights, participants will stay in the hospital.\\n* they will have their medical history taken, and a physical exam.\\n* blood will be drawn from a thin tube inserted in their hand or forearm. this will be done 3 times overall. a drop of blood will be taken from a finger prick 12 times overall.\\n* an antimalarial drug will be injected into the tube in the arm 4 times. each time the drug is given, participants will drink a small cup of either water or activated charcoal.\\n* for the following 3 days, participants will take an antimalarial pill.\\n* on day 7, participants will visit the hospital. a drop of blood from a finger prick will be tested for malaria parasites.\",\n",
      "            \"Phase\": \"phase2\",\n",
      "            \"Study Start Date\": \"2013-09\",\n",
      "            \"Expected Completion Date\": \"2015-07\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug Name\": \"drug: actidose aqua|drug: artesunate|drug: amodiaquine\"\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": \"malaria|severe malaria\"\n",
      "        },\n",
      "        \"Locations\": {\n",
      "            \"Location Name\": \"universite des sciencies, techniques et technologies de bamako, bamako, mali\"\n",
      "        }\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct01465048\",\n",
      "            \"Title\": \"optimisation of controlled human malaria infection using sporozoites administered by ne\n"
     ]
    }
   ],
   "source": [
    "# import pandas as pd\n",
    "# import json\n",
    " \n",
    "# # Function to convert each row to a JSON-like structure based on the prompt\n",
    "# def row_to_json(row):\n",
    "#     trial_info = {\n",
    "#         \"Trial ID\": row[\"NCT Number\"],\n",
    "#         \"Title\": row[\"Study Title\"],\n",
    "#         \"URL\": row[\"Study URL\"],\n",
    "#         \"Status\": row[\"Study Status\"],\n",
    "#         \"Brief Summary\": row[\"Brief Summary\"],\n",
    "#         \"Phase\": row[\"Phases\"],\n",
    "#         \"Study Start Date\": row[\"Start Date\"],\n",
    "#         \"Expected Completion Date\": row[\"Completion Date\"]\n",
    "    \n",
    "#     }\n",
    " \n",
    "#     # Assuming 'Interventions' field contains drug names\n",
    "#     drug_info = {\n",
    "#         \"Drug Name\": row[\"Interventions\"]\n",
    "#     }\n",
    " \n",
    "#     # Assuming 'Conditions' field contains disease names\n",
    "#     disease_info = {\n",
    "#         \"Disease Name\": row[\"Conditions\"]\n",
    "#     }\n",
    "\n",
    "#     locations_info = {\n",
    "#         \"Location Name\": row[\"Locations\"]\n",
    "#     }\n",
    " \n",
    "#     # Structuring the JSON object\n",
    "#     json_structure = {\n",
    "#         \"Trial\": trial_info,\n",
    "#         \"Drug/Intervention\": drug_info,\n",
    "#         \"Disease/Condition\": disease_info,\n",
    "#         # \"Sponsor\": sponsor_info,\n",
    "#         \"Locations\": locations_info\n",
    "#         # \"Outcome Measures\": outcome_info,\n",
    "#         # \"Participants/Patients\": participants_info\n",
    "#     }\n",
    " \n",
    "#     return json_structure\n",
    " \n",
    "# # Convert each row of the dataframe to JSON structure and store in a list\n",
    "# json_data = [row_to_json(row) for index, row in preprocessed_df.iterrows()]\n",
    " \n",
    "# # Convert the list to JSON string for display\n",
    "# json_string = json.dumps(json_data, indent=4)\n",
    " \n",
    "# # Display the first few JSON structures as a sample\n",
    "# print(json_string[:5000])  # Display only first 2000 characters for brevity\n",
    " \n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Convert the CSV data to a JSON-like structure (Updated Code)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct03334747\",\n",
      "            \"Title\": \"safety of kae609 in adults with uncomplicated plasmodium falciparum malaria.\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct03334747\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"kae609 will be evaluated primarily for hepatic safety of single and multiple doses in sequential cohorts with increasing doses.this study aims to determine the maximum safe dose of the investigational drug kae609 in malaria patients.\",\n",
      "            \"Phase\": \"phase2\",\n",
      "            \"Study Start Date\": \"2017-11-16\",\n",
      "            \"Expected Completion Date\": \"2019-11-23\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug\": [\n",
      "                \"kae609\",\n",
      "                \"coartem\"\n",
      "            ],\n",
      "            \"Procedure\": [],\n",
      "            \"Device\": [],\n",
      "            \"Behavioral\": [],\n",
      "            \"Combination_product\": [],\n",
      "            \"Biological\": [],\n",
      "            \"Radiation\": [],\n",
      "            \"Other\": []\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": [\n",
      "                \"malaria\"\n",
      "            ]\n",
      "        },\n",
      "        \"Locations\": [\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"lambarene\",\n",
      "                \"Country\": \"gabon\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"kintampo\",\n",
      "                \"Country\": \"ghana\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"navrango\",\n",
      "                \"Country\": \"ghana\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"bamako\",\n",
      "                \"Country\": \"mali\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"sotuba\",\n",
      "                \"Country\": \"mali\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"kigali\",\n",
      "                \"Country\": \"rwanda\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"bushenyi\",\n",
      "                \"Country\": \"uganda\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"kampala\",\n",
      "                \"Country\": \"uganda\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"novartis investigative site\",\n",
      "                \"City\": \"tororo\",\n",
      "                \"Country\": \"uganda\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct01190202\",\n",
      "            \"Title\": \"epidemiology study of malaria transmission intensity in africa\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct01190202\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"the aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (nct00866619).\",\n",
      "            \"Phase\": \"\",\n",
      "            \"Study Start Date\": \"2011-03-14\",\n",
      "            \"Expected Completion Date\": \"2013-12-20\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug\": [],\n",
      "            \"Procedure\": [\n",
      "                \"blood sampling\",\n",
      "                \"assessment of body temperature\"\n",
      "            ],\n",
      "            \"Device\": [],\n",
      "            \"Behavioral\": [],\n",
      "            \"Combination_product\": [],\n",
      "            \"Biological\": [],\n",
      "            \"Radiation\": [],\n",
      "            \"Other\": []\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": [\n",
      "                \"malaria\",\n",
      "                \"malaria vaccines\"\n",
      "            ]\n",
      "        },\n",
      "        \"Locations\": [\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"ouagadougou 01\",\n",
      "                \"Country\": \"burkina faso\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"lambarn\",\n",
      "                \"Country\": \"gabon\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"kintampo\",\n",
      "                \"Country\": \"ghana\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"kumasi\",\n",
      "                \"Country\": \"ghana\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"kisumu\",\n",
      "                \"Country\": \"kenya\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"lilongwe\",\n",
      "                \"Country\": \"malawi\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"dar-es-salaam\",\n",
      "                \"Country\": \"tanzania\"\n",
      "            },\n",
      "            {\n",
      "                \"Institution\": \"gsk investigational site\",\n",
      "                \"City\": \"korogwe\",\n",
      "                \"Country\": \"tanzania\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct01955382\",\n",
      "            \"Title\": \"evaluation of oral activated charcoal on antimalarial drug's ability to kill parasites in malian children with malaria\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct01955382\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"background:\\n\\n- malaria is caused by small parasites carried by some mosquitoes. people can get malaria if an infected mosquito bites them. malaria destroys red blood cells. most malaria is mild, but some children develop severe malaria, which kills about 660,000 people annually. about 9 in 10 who die of malaria are sub-saharan african children, most under 5 years old. scientists can save many lives if they find out how to prevent or relieve severe malaria.\\n\\nobjective:\\n\\n- to know if a common medicine called activated charcoal can reduce severe malaria symptoms.\\n\\neligibility:\\n\\n- children 2 to 11 years old with mild malaria who live in kenieroba, mali.\\n\\ndesign:\\n\\n* for the first 2 days and nights, participants will stay in the hospital.\\n* they will have their medical history taken, and a physical exam.\\n* blood will be drawn from a thin tube inserted in their hand or forearm. this will be done 3 times overall. a drop of blood will be taken from a finger prick 12 times overall.\\n* an antimalarial drug will be injected into the tube in the arm 4 times. each time the drug is given, participants will drink a small cup of either water or activated charcoal.\\n* for the following 3 days, participants will take an antimalarial pill.\\n* on day 7, participants will visit the hospital. a drop of blood from a finger prick will be tested for malaria parasites.\",\n",
      "            \"Phase\": \"phase2\",\n",
      "            \"Study Start Date\": \"2013-09\",\n",
      "            \"Expected Completion Date\": \"2015-07\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug\": [\n",
      "                \"actidose aqua\",\n",
      "                \"artesunate\",\n",
      "                \"amodiaquine\"\n",
      "            ],\n",
      "            \"Procedure\": [],\n",
      "            \"Device\": [],\n",
      "            \"Behavioral\": [],\n",
      "            \"Combination_product\": [],\n",
      "            \"Biological\": [],\n",
      "            \"Radiation\": [],\n",
      "            \"Other\": []\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": [\n",
      "                \"malaria\",\n",
      "                \"severe malaria\"\n",
      "            ]\n",
      "        },\n",
      "        \"Locations\": [\n",
      "            {\n",
      "                \"Institution\": \"universite des sciencies\",\n",
      "                \"City\": \"techniques et technologies de bamako\",\n",
      "                \"Country\": \"mali\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct01465048\",\n",
      "            \"Title\": \"optimisation of controlled human malaria infection using sporozoites administered by needle and syringe\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct01465048\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"this is an open label, human pilot study to optimise controlled human malaria infection (chmi) administered by plasmodium falciparum sporozoites (pfspz. volunteers will be inoculated with pfspz challenge. the route of administration and dose will vary in order to identify the optimal regimen that achieves the greatest infection rate in volunteers with plasmodium falciparum. all volunteers recruited will be healthy adults aged between 18 and 45 years. safety and infectivity data will be collected for each of the regimens.\",\n",
      "            \"Phase\": \"\",\n",
      "            \"Study Start Date\": \"2011-10\",\n",
      "            \"Expected Completion Date\": \"2013-02\"\n",
      "        },\n",
      "        \"Drug/Intervention\": {\n",
      "            \"Drug\": [],\n",
      "            \"Procedure\": [],\n",
      "            \"Device\": [],\n",
      "            \"Behavioral\": [],\n",
      "            \"Combination_product\": [],\n",
      "            \"Biological\": [\n",
      "                \"plasmodium falciparum sporozoites 2sites\",\n",
      "                \"plasmodium falciparum sporozoites 1 site\",\n",
      "                \"plasmodium falciparum sporozoites 1site\"\n",
      "            ],\n",
      "            \"Radiation\": [],\n",
      "            \"Other\": []\n",
      "        },\n",
      "        \"Disease/Condition\": {\n",
      "            \"Disease Name\": [\n",
      "                \"malaria\",\n",
      "                \"plasmodium falciparum\"\n",
      "            ]\n",
      "        },\n",
      "        \"Locations\": [\n",
      "            {\n",
      "                \"Institution\": \"centre for clinical vaccinology and tropical medicine\",\n",
      "                \"City\": \"university of oxford\",\n",
      "                \"Country\": \"united kingdom\"\n",
      "            }\n",
      "        ]\n",
      "    },\n",
      "    {\n",
      "        \"Trial\": {\n",
      "            \"Trial ID\": \"nct02458092\",\n",
      "            \"Title\": \"evaluate the safety and efficacy of plasmodium falciparum malaria protein 010 (fmp010) administered with adjuvant as01b\",\n",
      "            \"URL\": \"https://clinicaltrials.gov/study/nct02458092\",\n",
      "            \"Status\": \"completed\",\n",
      "            \"Brief Summary\": \"the purpose of this study is to determine whether an investigational malaria vaccine is safe and induces an immune response against malaria \n"
     ]
    }
   ],
   "source": [
    "# Re-importing necessary libraries as the execution state was reset\n",
    "import pandas as pd\n",
    "import json\n",
    "\n",
    "\n",
    "# Function to clean unwanted unicode characters like \"\\u00e9\" from a string\n",
    "def clean_unicode(text):\n",
    "    if isinstance(text, str):\n",
    "        return text.encode('ascii', 'ignore').decode('ascii')\n",
    "    return text\n",
    "\n",
    "# Updated function to include different intervention types and convert each row to a JSON-like structure\n",
    "def row_to_json(row):\n",
    "    trial_info = {\n",
    "        \"Trial ID\": clean_unicode(row[\"NCT Number\"]),\n",
    "        \"Title\": clean_unicode(row[\"Study Title\"]),\n",
    "        \"URL\": clean_unicode(row[\"Study URL\"]),\n",
    "        \"Status\": clean_unicode(row[\"Study Status\"]),\n",
    "        \"Brief Summary\": clean_unicode(row[\"Brief Summary\"]),\n",
    "        \"Phase\": clean_unicode(row[\"Phases\"]),\n",
    "        \"Study Start Date\": clean_unicode(row[\"Start Date\"]),\n",
    "        \"Expected Completion Date\": clean_unicode(row[\"Completion Date\"])\n",
    "    }\n",
    "\n",
    "    # Splitting interventions into different types if they exist\n",
    "    intervention_types = [\"drug\", \"procedure\", \"device\", \"behavioral\", \"combination_product\",\"biological\",\"radiation\",\"other\"]\n",
    "    interventions_info = {key.capitalize(): [] for key in intervention_types}  # Initialize all intervention types with empty lists\n",
    "    if pd.notnull(row[\"Interventions\"]):\n",
    "        interventions = row[\"Interventions\"].split('|')\n",
    "        for intervention in interventions:\n",
    "            intervention = intervention.strip()\n",
    "            for type_key in intervention_types:\n",
    "                if intervention.startswith(f\"{type_key}:\"):\n",
    "                    # Clean the intervention name and add it to the corresponding list\n",
    "                    intervention_name = intervention[len(f\"{type_key}:\"):].strip()\n",
    "                    intervention_cleaned = clean_unicode(intervention_name)\n",
    "                    # Capitalize the first letter of each intervention type for the output\n",
    "                    intervention_type_key = type_key.capitalize()\n",
    "                    interventions_info[intervention_type_key].append(intervention_cleaned)\n",
    "\n",
    "    # Splitting disease names if multiple diseases are listed\n",
    "    disease_info = {\n",
    "        \"Disease Name\": [clean_unicode(disease) for disease in row[\"Conditions\"].split('|')] if pd.notnull(row[\"Conditions\"]) else []\n",
    "    }\n",
    "\n",
    "    # Parsing locations into structured format\n",
    "    locations_info = []\n",
    "    if pd.notnull(row[\"Locations\"]):\n",
    "        locations_list = row[\"Locations\"].split('|')\n",
    "        for location in locations_list:\n",
    "            parts = [clean_unicode(part.strip()) for part in location.split(',')]\n",
    "            location_dict = {\n",
    "                \"Institution\": parts[0] if parts else None,\n",
    "                \"City\": parts[1] if len(parts) > 1 else None,\n",
    "                \"Country\": parts[-1] if parts else None\n",
    "            }\n",
    "            locations_info.append(location_dict)\n",
    "\n",
    "    # Structuring the JSON object\n",
    "    json_structure = {\n",
    "        \"Trial\": trial_info,\n",
    "        \"Drug/Intervention\": interventions_info,\n",
    "        \"Disease/Condition\": disease_info,\n",
    "        \"Locations\": locations_info\n",
    "    }\n",
    "\n",
    "    return json_structure\n",
    "\n",
    "# Convert each row of the dataframe to JSON structure and store in a list\n",
    "json_data = [row_to_json(row) for index, row in preprocessed_trials.iterrows()]\n",
    "\n",
    "# Convert the list to JSON string for display\n",
    "json_string = json.dumps(json_data, indent=4)\n",
    "\n",
    "# Display the first few JSON structures as a sample\n",
    "print(json_string[:10000])  # Display only first 2000 characters for brevity\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "tf_env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
